Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H T Silva

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Revista Da Associacao Medica Brasileira (1992)|July 1, 1995
[Xenotransplantation]V Bueno, H T Silva, L A Moura, et al.
Transplantation Proceedings|December 21, 2002
Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patientsE L M Sampaio, S I Park, C R Felipe, et al.
Transplantation Proceedings|June 15, 2004
FTY720 treatment prolongs skin graft survival in a completely incompatible strain combinationR S M Lima, M F Nogueira-Martins, H T Silva, et al.
Pediatric Transplantation|October 19, 2016
Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus diseaseG Varela-Fascinetto, C Benchimol, R Reyes-Acevedo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2014
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trialK Budde, S Bunnapradist, J M Grinyo, et al.
Revista Da Associacao Medica Brasileira (1992)|April 1, 1992
[ABO incompatibility in organ transplant. Report of case and review of the literature]H R Narciso, J O Bordin, H T Silva Júnior, et al.
Transplantation Proceedings|November 15, 2002
Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft lossP D Bianco, H T Silva, R Boni, et al.
Transplantation Proceedings|June 15, 2004
FTY720 impairs necrosis development after ischemia-reperfusion injuryC M S Oliveira, R C Borra, M Franco, et al.
Transplantation Proceedings|March 27, 2001
A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients-preliminary resultsP G Machado, C Garcia, C R Felipe, et al.
Journal of Molecular Modeling|November 7, 2016
Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modesGabriela C Araujo, Ricardo H T Silva, Luis P B Scott, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Revista Da Associacao Medica Brasileira (1992)|July 1, 1995
[Xenotransplantation]V Bueno, H T Silva, L A Moura, et al.
Transplantation Proceedings|December 21, 2002
Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patientsE L M Sampaio, S I Park, C R Felipe, et al.
Transplantation Proceedings|June 15, 2004
FTY720 treatment prolongs skin graft survival in a completely incompatible strain combinationR S M Lima, M F Nogueira-Martins, H T Silva, et al.
Pediatric Transplantation|October 19, 2016
Tolerability of up to 200 days of prophylaxis with valganciclovir oral solution and/or film-coated tablets in pediatric kidney transplant recipients at risk of cytomegalovirus diseaseG Varela-Fascinetto, C Benchimol, R Reyes-Acevedo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2014
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trialK Budde, S Bunnapradist, J M Grinyo, et al.
Revista Da Associacao Medica Brasileira (1992)|April 1, 1992
[ABO incompatibility in organ transplant. Report of case and review of the literature]H R Narciso, J O Bordin, H T Silva Júnior, et al.
Transplantation Proceedings|November 15, 2002
Cyclosporine from twice to single daily dosing: impact on renal function, mortality, and graft lossP D Bianco, H T Silva, R Boni, et al.
Transplantation Proceedings|June 15, 2004
FTY720 impairs necrosis development after ischemia-reperfusion injuryC M S Oliveira, R C Borra, M Franco, et al.
Transplantation Proceedings|March 27, 2001
A single-center open label randomized trial of the safety and efficacy of the use of sirolimus versus azathioprine in one-haplotype living related kidney transplant recipients-preliminary resultsP G Machado, C Garcia, C R Felipe, et al.
Journal of Molecular Modeling|November 7, 2016
Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modesGabriela C Araujo, Ricardo H T Silva, Luis P B Scott, et al.
Pageof 4